AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)-Reference-Cited by-同舟云学术

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)

Published:2020-12 Issue:S9 Volume:16 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Aisen Paul S.¹,Zhou Jin²,Irizarry Michael C.²,Kramer Lynn D²,Swanson Chad J.²,Dhadda Shobha²,Rabe Martin²,Krause Stephen²,Li David JianJun²,Raman Rema¹,Donohue Michael C.¹,Sethuraman Gopalan¹,Johnson Keith A.³,Sperling Reisa A.⁴

Affiliation:

1. Alzheimer's Therapeutic Research Institute University of Southern California San Diego CA USA

2. Eisai, Inc. Woodcliff Lake NJ USA

3. Division of Nuclear Medicine and Molecular Imaging Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA

4. Brigham and Women's Hospital Harvard Medical School Boston MA USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.044511

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology;Alzheimer's & Dementia;2024-07-04

2. Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies;NeuroImage;2023-10

3. Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal;Journal of Cerebral Blood Flow & Metabolism;2023-09-20

4. Artificial intelligence for dementia drug discovery and trials optimization;Alzheimer's & Dementia;2023-08-16

5. Age-Specific Barriers and Facilitators to Research Participation Amongst African Americans in Observational Studies of Memory and Aging;Journal of Racial and Ethnic Health Disparities;2023-08-09